Vimarsana
Biggest News Aggregation in the World

Page 5 - Realtime Dynamix News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Realtime Dynamix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Realtime Dynamix Today - Breaking & Trending Today

Spherix Global Insights Releases the Titles of Four Abstracts to be Presented at American Society of Nephrology (ASN) Kidney Week 2022 - Vimarsana News

Spherix Global Insights Releases the Titles of Four Abstracts to be Presented at American Society of Nephrology (ASN) Kidney Week 2022

/PRNewswire/ -- Spherix Global Insights, a leading market intelligence firm specializing in nephrology, is excited to announce the titles of four abstracts...

The Psoriatic Arthritis Landscape Continues to Evolve as New Launches Alter Dynamics in Both US and EU Markets, Spherix Reports - Vimarsana News

The Psoriatic Arthritis Landscape Continues to Evolve as New Launches Alter Dynamics in Both US and EU Markets, Spherix Reports

/PRNewswire/ -- TNF inhibitors continue to be the mainstay for treating psoriatic arthritis (PsA), largely driven by the gold standards, etanercept and...

The Psoriatic Arthritis Landscape Continues to Evolve as New Launches Alter Dynamics in Both US and EU Markets, Spherix Reports - Vimarsana News

The Psoriatic Arthritis Landscape Continues to Evolve as New Launches Alter Dynamics in Both US and EU Markets, Spherix Reports

/PRNewswire/ -- TNF inhibitors continue to be the mainstay for treating psoriatic arthritis (PsA), largely driven by the gold standards, etanercept and...

Genentech's Vabysmo Slowly Chips Away at Competition in the Neovascular (Wet) AMD Market While Regeneron's Eylea Holds its Ground (For Now), According to New Spherix Report - Vimarsana News

Genentech's Vabysmo Slowly Chips Away at Competition in the Neovascular (Wet) AMD Market While Regeneron's Eylea Holds its Ground (For Now), According to New Spherix Report

/PRNewswire/ -- Since the FDA approval in January this year, ophthalmologists have been very optimistic about their intended use of Genentech's Vabysmo...

Implications of Expanded Biosimilar Use in the United States' Dermatology, Gastroenterology, and Rheumatology Markets Highlighted in New Spherix Study - Vimarsana News

Implications of Expanded Biosimilar Use in the United States' Dermatology, Gastroenterology, and Rheumatology Markets Highlighted in New Spherix Study

/PRNewswire/ -- Biosimilars are biopharmaceutical products that are nearly identical copies of drugs that have previously been licensed (reference products),...